Antidepressant recalled due to presence of potentially cancer-causing impurity

Antidepressant recalled for contamination with dangerous chemical

FDA recalled 370k duloxetine bottles for carcinogenic N-nitroso contamination; second Breckenridge recall within 90 days. Supply chain governance signal: repeated manufacturing failures indicate systemic oversight gaps—critical for pharmatech and regulated-product leaders.